Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The annotations already mark readOnlyHint, openWorldHint, idempotentHint, and destructiveHint false, providing the safety profile. The description goes substantially beyond this by revealing internal cascading lookups, graceful degradation when external sources are unavailable, how identity resolution handles ambiguity (returns figi_candidates instead of asserting), and that unresolved identifiers are explicitly listed rather than omitted. It also labels each identifier with its source and explains the ISIN-to-LEI mapping for non-US issuers. This is rich behavioral detail that helps the agent predict outcomes.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long, but it packs a high density of information: examples, usage instruction, supported types, edge cases, and degradation behavior. It is well-structured with the primary usage directive near the beginning and detailed type-specific guidance later. It could be slightly trimmed for conciseness (e.g., some parenthetical asides), but every sentence contributes to correct usage. It earns a 4 for being effectively structured without excessive fluff.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's complexity (two entity types, multiple external sources, cascading lookups, ambiguity handling) and no output schema, the description is remarkably complete. It covers input formats, interpretation of ambiguous inputs, degradation behavior, unresolved identifier semantics, source labeling, and the distinction between entity resolution and security resolution. An agent would have clear expectations about what the tool returns and how to handle edge cases. There is no missing critical information for effective invocation.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100% for both parameters, but the description adds essential semantics beyond the schema. For 'type', it clarifies the meaning of 'company' and 'drug' and what each resolves to. For 'value', it gives concrete examples ('AAPL', '0000320193') and critical guidance on passing only the entity name, not the full noun phrase, with a specific warning about trailing security-class words. This level of detail is far more actionable than the schema's brief descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete example queries and states the exact action: resolving user-spoken names to canonical/official identifiers that other tools require as input. It explicitly differentiates itself from siblings by noting that other tools depend on these IDs, and it covers two distinct entity types (company, drug) with detailed scope. This is a specific, unambiguous statement of purpose.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description contains a direct instruction: 'Use FIRST whenever you have a name but need an ID.' It also explains when it should be preferred (replacing 2-3 manual lookups) and covers important caveats (e.g., non-equity instruments, ambiguous names returning candidates, graceful degradation). While it doesn't name specific alternative tools, the 'use FIRST' directive and the emphasis on being the canonical name-to-ID resolver make usage guidance explicit and actionable.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

C2.8/5.0
Disambiguation2/5

Many tools overlap or are near-duplicates: ask_pipeworx and ask_pipeworx_beta are currently identical, and there are multiple prediction-market tools (polymarket_arbitrage, polymarket_edges, polymarket_edge_tracker, polymarket_fill_risk, polymarket_kalshi_spread) with fine-grained but confusing distinctions. The mix of Bitfinex market data tools with an unrelated Pipeworx research suite makes tool selection genuinely ambiguous.

Naming Consistency2/5

All names use lowercase snake_case, but the semantic pattern is inconsistent: bare nouns (ticker, candles, trades, stats), verb_noun phrases (validate_claim, compare_entities, generate_llms_txt), and large prefixed families (ask_pipeworx*, polymarket_*) coexist. This mixed convention gives no reliable cue to a tool's function.

Tool Count2/5

42 tools is excessive for a server named 'Bitfinex'. Only about a dozen tools actually relate to the crypto exchange (ticker, candles, trades, book, liquidations, etc.); the rest are a grab bag of Pipeworx research, prediction markets, memory, and subscription features. The count bloats the surface and obscures the server's purpose.

Completeness2/5

The set has no coherent scope. For a Bitfinex server, there are no account/trading tools, only market data. For the buried Pipeworx functionality, the surface is extensive but unrelated to Bitfinex. The overall result is an incomplete hodgepodge with no clear lifecycle or workflow for a single domain.